Halpin, D. M. G. et al. The GOLD summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int. J. Tuberc. Lung Dis. 23, 1131–1141 (2019).

Article  CAS  PubMed  Google Scholar 

Meghji, J. et al. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet 397, 928–940 (2021).

Article  PubMed  Google Scholar 

Wang, C. et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 391, 1706–1717 (2018).

Article  PubMed  Google Scholar 

Adeloye, D. et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J. Glob. Health 5, 020415 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Adeloye, D. et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir. Med. 10, 447–458 (2022).

Article  PubMed  PubMed Central  Google Scholar 

GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171 (2015).

Article  Google Scholar 

Chen, S. et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: A Health-Augmented Macroeconomic Modelling Study. Lancet Glob. Health 11, e1183–e1193 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Florman, K. E. H. et al. Unmet diagnostic and therapeutic opportunities for chronic obstructive Pulmonary disease in low- and middle-income countries. Am. J. Respir. Crit. Care Med. 208, 442–450 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Hurst, J. R. et al. Challenges in the implementation of chronic obstructive Pulmonary disease guidelines in low- and middle-income countries: an official American thoracic society workshop report. Ann. Am. Thorac. Soc. 18, 1269–1277 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Chronic Obstructive Pulmonary Disease Group of Chinese Thoracic Society; Chronic Obstructive Pulmonary Disease Committee of Chinese Association of Chest Physician. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021). Zhonghua Jie He He Hu Xi Za Zhi 44, 170–205 (2021).

Google Scholar 

Agustí, A. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur. Respir. J. 61, 2300239 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Kibirige, D. et al. Availability and affordability of medicines and diagnostic tests recommended for management of asthma and chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Allergy, Asthma, Clin. Immunol. 15, 14 (2019).

Article  PubMed  Google Scholar 

Mendis, S. et al. Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions. Int. J. Hypertens. 2012, 584041 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabyshova, A. et al. Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settings. npj Prim. Care Respir. Med. 32, 20 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Cameron, A. et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373, 240–249 (2009).

Article  CAS  PubMed  Google Scholar 

Stolbrink, M. et al. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review. Lancet Glob. Health 10, e1423–e1442 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xi, X. et al. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China. BMC Health Serv. Res. 15, 345 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Dong, Z. et al. Availability, prices and affordability of essential medicines in Zhejiang Province, China. PLoS One 15, e0241761 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, H. et al. Perspectives and management of atypical Asthma in Chinese specialists and primary care practitioners-a Nationwide Questionnaire Survey. Front. Med. 8, 727381 (2021).

Article  Google Scholar 

Zeng, Y. et al. Current status of the treatment of COPD in China: A Multicenter Prospective Observational Study. Int. J. Chron. Obstr. Pulmon. Dis. 15, 3227–3237 (2020).

Article  Google Scholar 

Yang, T. et al. REALizing and improving management of stable COPD in China: Results of a Multicentre, Prospective, Observational Study (REAL). Ther. Adv. Respir. Dis. 17, 17534666231178692 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Plum, C. et al. Availability of diagnostic services and essential medicines for non-communicable respiratory diseases in African countries. Int. J. Tuberc. Lung Dis. 25, 120–125 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ozoh, O. B. et al. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria. Trop. Med. Int. Health 26, 54–65 (2021).

Article  PubMed  Google Scholar 

Lu, Y. X. et al. Association between intention to call EMS in stroke patients and level of hospital classification and emergency medical service usage among stroke patients in China. Neurol. Neurochir. Pol. 55, 582–591 (2021).

Article  PubMed  Google Scholar 

He, L. et al. Healthcare quality and mortality among patients hospitalized for heart failure by hospital level in Beijing, China. ESC. Heart Fail 8, 1186–1194 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Mao, R. et al. Stable chronic obstructive pulmonary disease (COPD) management under a tiered medical system in China. Int. J. Chron. Obstr. Pulmon. Dis. 17, 181–194 (2022).

Article  CAS  Google Scholar 

Su, M. et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet 390, 2559–2568 (2017).

Article  PubMed  Google Scholar 

Lu, Y. et al. Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China. JAMA Netw. Open 4, e2127573 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Husain, M. J. et al. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability. J. Am. Heart Assoc. 9, e015302 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Lykkegaard, J. et al. Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark - specialist care versus GP care only. BMC Health Serv. Res. 22, 408 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Chinese guideline for management of chronic obstructive pulmonary disease in primary care. Chin. J. Gen. Practitioners. 23, 578–602. https://doi.org/10.3760/cma.j.cn114798-20240326-00174 (2024).